Vascular Closure Devices Market Size, Share, Demand, Trends, Growth Rate (CAGR of 5.9%) and Forecast 2023-2028

According to IMARC Group's latest research report, titled "Vascular Closure Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," offers a comprehensive analysis of the industry, which comprises insights into the market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global vascular closure devices market size reached US$ 1.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.

Get Sample Copy of Report at - https://www.imarcgroup.com/vascular-closure-devices-market/requestsample

Vascular Closure Devices Market Overview:

Vascular closure devices (VCDs) are innovative medical tools designed to facilitate the closure of arterial or venous puncture sites following various diagnostic or interventional cardiovascular procedures. They are primarily utilized to achieve hemostasis, preventing excessive bleeding and minimizing the risk of complications associated with manual compression. VCDs are particularly advantageous in situations where manual compression may be challenging or impractical, such as in patients with coagulopathy, obesity, or arterial access sites located in challenging anatomical locations. They employ different mechanisms to achieve hemostasis. One common type is the passive closure device, which includes collagen plugs or sealants. Additionally, they work by promoting the formation of blood clots within the puncture site, effectively sealing off the vessel. Once the clotting process is complete, the body absorbs the plug or sealant, leaving behind a healed puncture site.

Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/vascular-closure-devices-market

Vascular Closure Devices Market Trends:

The escalating healthcare expenditure majorly drives the global market. This can be supported by the increasing prevalence of conditions, such as heart disease, peripheral arterial disease, and aortic diseases. Along with this, the rising demand for catheterization and interventional procedures to diagnose and treat CVDs is significantly supporting the market. In addition, the escalating demand for femoral access to vascular procedures, including coronary angiography and other interventional techniques, is influencing the demand for non-invasive procedures.

This, in confluence with the rising need for advanced surgical equipment in hospitals and surgical centers, is also positively influencing the market. Apart from this, the increasing emphasis placed by physicians on effective blood loss management during surgical procedures is contributing to the market. Furthermore, the introduction of large-bore vascular closure devices, evident in the growing number of registrations for innovative devices, is creating a positive market outlook.

Key Market Segmentation:

Competitive Landscape with Key Players:

• Abbott Laboratories
• Cardiva Medical Inc. (Haemonetics Corporation)
• Cordis Corporation (Cardinal Health Inc.)
• ENDOCOR GmbH & Co. KG
• Merit Medical Systems Inc.
• Morris Innovative Inc.
• Teleflex Incorporated
• Terumo Medical Corporation (Terumo Corporation)
• Transluminal Technologies LLC
• Vasorum Ltd.

Product Insights:

• Passive Approximators
o Collagen Plugs
o Sealant or Gel-Based Devices
o Compression-Assist Devices
• Active Approximators
o Suture-Based Devices
o Clip-Based Devices
• External Hemostatic Devices

Access Insights:

• Femoral Access
• Radial Access

Procedure Insights:

• Interventional Cardiology
• Interventional Radiology/Vascular Surgery

End-User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Others

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance
• Market Outlook
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Reports:

• https://www.imarcgroup.com/cardiac-pacemaker-market
• https://www.imarcgroup.com/sterility-testing-market
• https://www.imarcgroup.com/ev-charging-cables-market
• https://www.imarcgroup.com/enterprise-asset-management-market
• https://www.imarcgroup.com/immune-checkpoint-inhibitors-market

Contact us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysi for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.